Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | V559G |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | KIT V559G lies within the juxtamembrane domain (exon 11) of the Kit protein (PMID: 12879016). V559G results in constitutive phosphorylation of Kit in a patient sample (PMID: 15897563), but has not been fully biochemically characterized and therefore, its effect on Kit protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT exon11 KIT V559X KIT V559G |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727444T>G |
cDNA | c.1676T>G |
Protein | p.V559G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001385285.1 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727444T>G | c.1676T>G | p.V559G | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
KIT V559G | Advanced Solid Tumor | sensitive | Axitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Inlyta (axitinib) inhibited KIT phosphorylation and proliferation of transformed cells expressing KIT V559G in culture (PMID: 31205508). | 31205508 |
KIT V559G | Advanced Solid Tumor | sensitive | Imatinib | Preclinical - Cell culture | Actionable | In a preclinical study, Gleevec (imatinib) inhibited proliferation of transformed cells expressing KIT V559G in culture (PMID: 35194937). | 35194937 |
KIT V559G | Advanced Solid Tumor | sensitive | Nintedanib | Preclinical - Cell culture | Actionable | In a preclinical study, Ofev (nintedanib) inhibited Kit autophosphorylation and proliferation of transformed cells expressing KIT V559G in culture (PMID: 35194937). | 35194937 |
KIT V559G | Advanced Solid Tumor | sensitive | Sunitinib | Preclinical - Cell culture | Actionable | In a preclinical study, Sutent (sunitinib) inhibited proliferation of transformed cells expressing KIT V559G in culture (PMID: 35194937). | 35194937 |